Albemarle Past Earnings Performance

Past criteria checks 0/6

Albemarle has been growing earnings at an average annual rate of 12.8%, while the Chemicals industry saw earnings growing at 7% annually. Revenues have been growing at an average rate of 24.8% per year.

Key information

12.8%

Earnings growth rate

11.5%

EPS growth rate

Chemicals Industry Growth13.1%
Revenue growth rate24.8%
Return on equity-17.4%
Net Margin-30.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Albemarle makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

WBAG:ALBE Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,502-1,96764789
30 Jun 247,458-55465588
31 Mar 248,39832665489
31 Dec 239,6171,57364486
30 Sep 239,8823,32457083
30 Jun 239,6633,91853280
31 Mar 238,7733,67548376
31 Dec 227,3202,69043972
30 Sep 225,5931,55439364
30 Jun 224,33226436559
31 Mar 223,62628136355
31 Dec 213,32812433354
30 Sep 213,31321245057
30 Jun 213,22970343958
31 Mar 213,21936441858
31 Dec 203,12937642759
30 Sep 203,24238241158
30 Jun 203,37543843060
31 Mar 203,49650745359
31 Dec 193,58953347058
30 Sep 193,51957244060
30 Jun 193,41754743261
31 Mar 193,38569541764
31 Dec 183,37569441570
30 Sep 183,31134641075
30 Jun 183,28833541680
31 Mar 183,17213542181
31 Dec 173,0725542079
30 Sep 172,91131543177
30 Jun 172,81030241675
31 Mar 172,74228239678
31 Dec 162,67744235579
30 Sep 162,70356030382
30 Jun 162,74251029784
31 Mar 162,79146829986
31 Dec 152,82630230089
30 Sep 152,70212439789
30 Jun 152,65214938289
31 Mar 152,53819036189
31 Dec 142,44620335588
30 Sep 142,48737718388
30 Jun 142,43538817885
31 Mar 142,40838517385
31 Dec 132,39440915882

Quality Earnings: ALBE is currently unprofitable.

Growing Profit Margin: ALBE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALBE is unprofitable, but has reduced losses over the past 5 years at a rate of 12.8% per year.

Accelerating Growth: Unable to compare ALBE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALBE is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).


Return on Equity

High ROE: ALBE has a negative Return on Equity (-17.39%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 21:31
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Albemarle Corporation is covered by 48 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher KapschAegis Capital Corporation
William SeleskyArgus Research Company
Benjamin KalloBaird